This project aims to develop and optimize the commercialization strategy for OrganoPlatform and its supporting equipment to enable broader adoption of high-throughput 3D tissue culture systems in pharmaceutical R&D and preclinical testing.
This record is a historical disbursement from Canada's open grants database — it documents a past payment, not an active program accepting applications.
View disbursement record →